CA Stock MarketDetailed Quotes

IPCI.H IntelliPharmaCeutics International Inc

Watchlist
  • 0.080
  • 0.0000.00%
15min DelayMarket Closed Mar 5 10:01 ET
2.65MMarket Cap-655P/E (TTM)

IntelliPharmaCeutics International Inc Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Aug 31, 2023
(Q2)May 31, 2023
(Q1)Feb 28, 2023
(FY)Nov 30, 2022
(Q4)Nov 30, 2022
(Q3)Aug 31, 2022
(Q2)May 31, 2022
(Q1)Feb 28, 2022
(FY)Nov 30, 2021
(Q4)Nov 30, 2021
Assets
Current assets
Cash, cash equivalents and short term investments
402.33%400.1K
-57.28%159.27K
-67.10%69.55K
-89.15%83.72K
-89.15%83.72K
-92.81%79.65K
-84.91%372.8K
4.29%211.36K
282.06%771.95K
282.06%771.95K
-Cash and cash equivalents
402.33%400.1K
-57.28%159.27K
-67.10%69.55K
-89.15%83.72K
-89.15%83.72K
-92.81%79.65K
-84.91%372.8K
4.29%211.36K
282.06%771.95K
282.06%771.95K
-Accounts receivable
--0
--333.58K
466.29%211.53K
--602
--602
----
----
--37.35K
--0
--0
-Other receivables
30.98%3.73M
30.73%3.49M
35.00%3.31M
35.50%3.07M
35.50%3.07M
40.32%2.85M
28.60%2.67M
38.43%2.45M
35.95%2.26M
35.95%2.26M
Total current assets
55.35%861.9K
4.97%953.45K
-10.78%735.37K
-55.32%492.51K
-55.32%492.51K
-69.92%554.83K
-72.19%908.29K
-5.87%824.22K
-25.47%1.1M
-25.47%1.1M
Non current assets
-Accumulated depreciation
-2.62%-6.8M
-2.81%-6.76M
-3.00%-6.72M
-3.19%-6.68M
-3.19%-6.68M
-3.43%-6.62M
-3.69%-6.57M
-3.95%-6.52M
-4.21%-6.47M
-4.21%-6.47M
Regulatory assets
0.00%268.18K
124.39%601.76K
57.01%479.71K
23.09%389.38K
23.09%389.38K
-44.38%268.18K
-55.41%268.18K
-36.63%305.53K
-69.83%316.33K
-69.83%316.33K
Total assets
0.00%268.18K
0.00%268.18K
0.00%268.18K
22.90%388.78K
22.90%388.78K
-44.38%268.18K
-44.38%268.18K
-44.38%268.18K
-34.39%316.33K
-34.39%316.33K
Liabilities
Current liabilities
Current debt and capital lease obligation
10.62%2.22M
9.41%2.24M
11.07%2.3M
21.31%2.33M
21.31%2.33M
4.44%2.01M
5.96%2.05M
0.48%2.07M
-9.24%1.92M
-9.24%1.92M
-Current debt
10.87%2.18M
9.75%2.16M
11.01%2.16M
12.68%2.16M
12.68%2.16M
4.59%1.96M
6.34%1.97M
0.27%1.95M
-1.95%1.92M
-1.95%1.92M
-Current capital lease obligation
-0.78%43.06K
1.54%84.47K
12.04%138.12K
--165.44K
--165.44K
-1.76%43.4K
-2.32%83.19K
3.80%123.28K
--0
--0
-accounts payable
-9.39%3.86M
-14.29%3.67M
-1.95%3.82M
-0.39%3.76M
-0.39%3.76M
12.89%4.26M
4.88%4.29M
-8.46%3.89M
-7.90%3.78M
-7.90%3.78M
-Total tax payable
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Current accrued expenses
43.07%3.52M
21.10%3.28M
24.27%3.07M
24.15%2.82M
24.15%2.82M
31.91%2.46M
45.03%2.71M
41.47%2.47M
27.66%2.27M
27.66%2.27M
Current deferred liabilities
--213.73K
----
----
----
----
----
----
----
----
----
Current liabilities
24.61%14.44M
8.39%12.72M
14.88%12.53M
17.14%12.01M
17.14%12.01M
20.41%11.59M
17.29%11.74M
10.50%10.9M
5.68%10.25M
5.68%10.25M
Non current liabilities
Non current accrued expenses
-20.21%703.93K
-19.66%781.96K
-19.27%860.07K
-5.49%939.52K
-5.49%939.52K
-45.28%882.2K
-43.17%973.3K
-41.06%1.07M
-47.90%994.11K
-47.90%994.11K
Total non current liabilities
24.61%14.44M
8.39%12.72M
14.88%12.53M
17.14%12.01M
17.14%12.01M
20.41%11.59M
17.29%11.74M
10.50%10.9M
5.68%10.25M
5.68%10.25M
Shareholders'equity
Share capital
0.00%49.18M
0.00%49.18M
0.00%49.18M
0.00%49.18M
0.00%49.18M
0.00%49.18M
0.00%49.18M
6.57%49.18M
6.57%49.18M
6.57%49.18M
-common stock
0.00%49.18M
0.00%49.18M
0.00%49.18M
0.00%49.18M
0.00%49.18M
0.00%49.18M
0.00%49.18M
6.57%49.18M
6.57%49.18M
6.57%49.18M
Additional paid-in capital
1.01%45.1M
1.01%45.1M
1.01%45.1M
1.06%45.1M
1.06%45.1M
-0.02%44.65M
0.26%44.65M
0.54%44.65M
0.61%44.63M
0.61%44.63M
Gains losses not affecting retained earnings
0.00%284.42K
0.00%284.42K
0.00%284.42K
0.00%284.42K
0.00%284.42K
0.00%284.42K
0.00%284.42K
0.00%284.42K
0.00%284.42K
0.00%284.42K
Other equity interest
--193.62K
--192.41K
--186.12K
-14.49%12K
-14.49%12K
----
----
----
--14.04K
--14.04K
Total equity
8.96%1.57M
-7.77%1.74M
-15.57%1.6M
-31.69%1.43M
-31.69%1.43M
-58.43%1.44M
-62.21%1.88M
-29.57%1.89M
-38.10%2.1M
-38.10%2.1M
(Q3)Aug 31, 2023(Q2)May 31, 2023(Q1)Feb 28, 2023(FY)Nov 30, 2022(Q4)Nov 30, 2022(Q3)Aug 31, 2022(Q2)May 31, 2022(Q1)Feb 28, 2022(FY)Nov 30, 2021(Q4)Nov 30, 2021
Assets
Current assets
Cash, cash equivalents and short term investments 402.33%400.1K-57.28%159.27K-67.10%69.55K-89.15%83.72K-89.15%83.72K-92.81%79.65K-84.91%372.8K4.29%211.36K282.06%771.95K282.06%771.95K
-Cash and cash equivalents 402.33%400.1K-57.28%159.27K-67.10%69.55K-89.15%83.72K-89.15%83.72K-92.81%79.65K-84.91%372.8K4.29%211.36K282.06%771.95K282.06%771.95K
-Accounts receivable --0--333.58K466.29%211.53K--602--602----------37.35K--0--0
-Other receivables 30.98%3.73M30.73%3.49M35.00%3.31M35.50%3.07M35.50%3.07M40.32%2.85M28.60%2.67M38.43%2.45M35.95%2.26M35.95%2.26M
Total current assets 55.35%861.9K4.97%953.45K-10.78%735.37K-55.32%492.51K-55.32%492.51K-69.92%554.83K-72.19%908.29K-5.87%824.22K-25.47%1.1M-25.47%1.1M
Non current assets
-Accumulated depreciation -2.62%-6.8M-2.81%-6.76M-3.00%-6.72M-3.19%-6.68M-3.19%-6.68M-3.43%-6.62M-3.69%-6.57M-3.95%-6.52M-4.21%-6.47M-4.21%-6.47M
Regulatory assets 0.00%268.18K124.39%601.76K57.01%479.71K23.09%389.38K23.09%389.38K-44.38%268.18K-55.41%268.18K-36.63%305.53K-69.83%316.33K-69.83%316.33K
Total assets 0.00%268.18K0.00%268.18K0.00%268.18K22.90%388.78K22.90%388.78K-44.38%268.18K-44.38%268.18K-44.38%268.18K-34.39%316.33K-34.39%316.33K
Liabilities
Current liabilities
Current debt and capital lease obligation 10.62%2.22M9.41%2.24M11.07%2.3M21.31%2.33M21.31%2.33M4.44%2.01M5.96%2.05M0.48%2.07M-9.24%1.92M-9.24%1.92M
-Current debt 10.87%2.18M9.75%2.16M11.01%2.16M12.68%2.16M12.68%2.16M4.59%1.96M6.34%1.97M0.27%1.95M-1.95%1.92M-1.95%1.92M
-Current capital lease obligation -0.78%43.06K1.54%84.47K12.04%138.12K--165.44K--165.44K-1.76%43.4K-2.32%83.19K3.80%123.28K--0--0
-accounts payable -9.39%3.86M-14.29%3.67M-1.95%3.82M-0.39%3.76M-0.39%3.76M12.89%4.26M4.88%4.29M-8.46%3.89M-7.90%3.78M-7.90%3.78M
-Total tax payable --0--0--0--0--0--0--0--0--0--0
Current accrued expenses 43.07%3.52M21.10%3.28M24.27%3.07M24.15%2.82M24.15%2.82M31.91%2.46M45.03%2.71M41.47%2.47M27.66%2.27M27.66%2.27M
Current deferred liabilities --213.73K------------------------------------
Current liabilities 24.61%14.44M8.39%12.72M14.88%12.53M17.14%12.01M17.14%12.01M20.41%11.59M17.29%11.74M10.50%10.9M5.68%10.25M5.68%10.25M
Non current liabilities
Non current accrued expenses -20.21%703.93K-19.66%781.96K-19.27%860.07K-5.49%939.52K-5.49%939.52K-45.28%882.2K-43.17%973.3K-41.06%1.07M-47.90%994.11K-47.90%994.11K
Total non current liabilities 24.61%14.44M8.39%12.72M14.88%12.53M17.14%12.01M17.14%12.01M20.41%11.59M17.29%11.74M10.50%10.9M5.68%10.25M5.68%10.25M
Shareholders'equity
Share capital 0.00%49.18M0.00%49.18M0.00%49.18M0.00%49.18M0.00%49.18M0.00%49.18M0.00%49.18M6.57%49.18M6.57%49.18M6.57%49.18M
-common stock 0.00%49.18M0.00%49.18M0.00%49.18M0.00%49.18M0.00%49.18M0.00%49.18M0.00%49.18M6.57%49.18M6.57%49.18M6.57%49.18M
Additional paid-in capital 1.01%45.1M1.01%45.1M1.01%45.1M1.06%45.1M1.06%45.1M-0.02%44.65M0.26%44.65M0.54%44.65M0.61%44.63M0.61%44.63M
Gains losses not affecting retained earnings 0.00%284.42K0.00%284.42K0.00%284.42K0.00%284.42K0.00%284.42K0.00%284.42K0.00%284.42K0.00%284.42K0.00%284.42K0.00%284.42K
Other equity interest --193.62K--192.41K--186.12K-14.49%12K-14.49%12K--------------14.04K--14.04K
Total equity 8.96%1.57M-7.77%1.74M-15.57%1.6M-31.69%1.43M-31.69%1.43M-58.43%1.44M-62.21%1.88M-29.57%1.89M-38.10%2.1M-38.10%2.1M

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
CA
Overall
Symbol
Latest Price
% Chg

No Data